We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children's, WellSpan Health, John Doerr, Rick Klausner, and others. The ideal candidate navigates complex, high-stakes ambiguity with ease, translates high-level strategic directives into rigorous analytical programs, and possesses executive-level business judgment to influence product roadmaps and customer partnerships.